
Reckitt Benckiser’s UK general manager Camillo Pane has been promoted to senior vice president – global category officer healthcare. Reporting …

Recognition for digital pharma marketing has been slowly increasing over the last couple of years and last night’s Best of …

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …
The EMA has extended the breast cancer licence for Roche’s Avastin after initially restricting the drug’s use. The decision comes …
Katy Pogson has been promoted to associate director at Red Door Communications and joins its management team. She started at …

Langland and McCann Healthcare Sydney took home the highly coveted ‘Best of Show’ awards at the 2011 IPA Best of …

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …
Mark Johnson has joined London-based life science recruitment company Talentmark as a managing consultant. For the past eight years Mark …
AstraZeneca has signed a deal with PTC Therapeutics to use the company’s proprietary drug discovery platform to discover new cancer …

An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …
Some years ago, regulatory affairs (RA) was seen by some as merely a ‘front office’ function, providing a necessary interface …
Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …

NICE has decided not to recommend Roche’s Tarceva because of uncertainty over how long the lung cancer drug can extend …

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …
Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …
There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …
SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labeling and …
A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …
The debt crisis afflicting Greece is starting to affect the country’s hospitals as pharma companies refuse to deliver drugs. Roche …

Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …